Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Phys Rev E ; 100(1-1): 010701, 2019 Jul.
Article in English | MEDLINE | ID: mdl-31499900

ABSTRACT

The unique nanometer-sized helical structure in SmC_{α}^{*} may sometimes evolve continuously to the micrometer-sized one in SmC^{*}; conceivably ferroelectric SmC_{α}^{*} is to be unwound by an applied electric field. By drawing electric-field-induced birefringence contours in the field-temperature phase diagram and by studying the superlattice structure of the field-induced subphase with resonant x-ray scattering, we established that an applied field unexpectedly stabilizes the well-known antiferroelectric four-layer biaxial subphase as well as the other prototypal ferrielectric three-layer one in the SmC_{α}^{*} temperature range; the effective long-range interlayer interaction due to the discrete flexoelectric effect actually plays an important role in stabilizing not only the biaxial subphases but also the optically uniaxial SmC_{α}^{*} subphase, contrary to the notion that the competition between the direct interactions of the nearest-neighbor layers and those of the next-nearest-neighbor layers should be required for the nanometer-sized helical structure.

2.
Int J Pharm ; 511(2): 890-8, 2016 Sep 25.
Article in English | MEDLINE | ID: mdl-27477103

ABSTRACT

The effect of the glycolipid, hexadecyl-ß-d-glucopyranoside, incorporated in microemulsions (ME(1)) towards the enhancement of skin absorption and skin permeation of Diclofenac sodium (DS(2)) was evaluated. A Franz diffusion cell with a piece of pig's ear epidermis indicated that the optimized ME formulation with glycolipid (0.05wt%) exhibited significantly higher permeability than the conventional formulations. The releasing profiles of DS from ME formulations exhibited first order release kinetics resembling a diffusion controlled release model for the first 8h. Incorporating hexadecyl-ß-D glucopyranoside in ME formulations shows significant potential as a delivery vehicle in the cosmetics and pharmaceutical industry.


Subject(s)
Diclofenac/metabolism , Drug Delivery Systems/methods , Emulsions/metabolism , Epidermis/metabolism , Glycolipids/metabolism , Animals , Delayed-Action Preparations/administration & dosage , Delayed-Action Preparations/chemistry , Delayed-Action Preparations/metabolism , Diclofenac/administration & dosage , Diclofenac/chemistry , Drug Liberation , Emulsions/administration & dosage , Emulsions/chemistry , Epidermis/drug effects , Glycolipids/administration & dosage , Glycolipids/chemistry , Organ Culture Techniques , Skin Absorption/drug effects , Skin Absorption/physiology , Swine
SELECTION OF CITATIONS
SEARCH DETAIL
...